BioSpace News Archive

A Kaiser Permanente analysis of pregnant patients who tested positive for the coronavirus found more than double the risk of poor outcomes including preterm birth, venous thromboembolism, and severe maternal morbidity, which includes conditions such as acute respiratory distress syndrome and sepsis.

Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced the closing of a $300 million note purchase agreement with funds managed by Athyrium Capital Management, LP, a leading healthcare-focused investment firm.

Twist Bioscience Corporation today announced the launch of specific synthetic RNA positive controls for SARS-CoV-2 encapsulated in proprietary stainless steel minicapsules provided by Imagene SA.

ABclonal Technology, a rapidly growing life science research and diagnostic reagents manufacturer, announced it has joined the Industry Advisory Committee at YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins, to tackle the reproducibility crisis observed in biomedical research.

AnHeart Therapeutics today announced a poster presentation for ROS1 inhibitor taletrectinib at the European Lung Cancer Congress 2022, held in Prague, Czech Republic, and virtually, March 30-April 2, 2022.

Aulos Bioscience has shared new preclinical data demonstrating solid tumor elimination when dosing AU-007, a monoclonal antibody computationally designed by Biolojic Design.

UroGen Pharma Ltd. today announced financial results for the fourth quarter and full year ended December 31, 2021, and overview of recent developments.

Wave Life Sciences Ltd. (Nasdaq: WVE), announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate virtually in an analyst-led fireside chat at the Stifel 2022 CNS Days event on Monday, March 28, 2022, at 9:15 a.m. EDT.

Jasper Therapeutics, Inc. today announced changes to its management team, including the promotions of Jeet Mahal to the newly created position of Chief Operating Officer, and of Wendy Pang, M.D., Ph.D., to Senior Vice President of Research and Translational Medicine.

Artelo Biosciences, Inc. today reported financial and operating results for the four month transitional period from September 1, 2021 to December 31, 2021 and provided a business update.